List of works by Susan Ellard

A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205

scientific article published on 15 March 2019

A Retrospective Review of Chemotherapy for Patients with Small Bowel Adenocarcinoma in British Columbia.

scientific article

A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149).

scientific article published on 19 June 2010

A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer.

scientific article

A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.

scientific article

A preliminary trial examining a 'real world' approach for increasing physical activity among breast cancer survivors: findings from project MOVE

scientific article published on 27 March 2019

A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer.

scientific article

A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer

scientific article published on 18 December 2017

A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer.

scientific article

A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209.

scientific article

A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.

scientific article

Abiraterone and increased survival in metastatic prostate cancer

scientific article (publication date: 26 May 2011)

Acceptability and satisfaction of Project MOVE: a pragmatic feasibility trial aimed at increasing physical activity in female breast cancer survivors.

scientific article

Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer

scientific article

Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.

scientific article published on 23 October 2007

Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole.

scientific article published on 23 February 2009

Influence of nurse navigation on wait times for breast cancer care in a Canadian regional cancer center

scientific article published on 19 February 2014

Innovative approach for increasing physical activity among breast cancer survivors: protocol for Project MOVE, a quasi-experimental study

scientific article published on 16 August 2016

Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31.

scientific article published on 16 March 2015

Molecular predictive factors in patients receiving trastuzumab-based chemotherapy for metastatic disease

scientific article published on 01 August 2006

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

scientific article published on 11 November 2019

Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumab.

scientific article

Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer.

scientific article published on 28 August 2014

Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer

scientific article published on 07 April 2014

Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.

scientific article published on 17 August 2009

Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.

scientific article

Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer

scientific article published on 17 November 2015

Utilizing RE-AIM to examine the translational potential of Project MOVE, a novel intervention for increasing physical activity levels in breast cancer survivors

scientific article published on 01 July 2019

Paulina is supported by:

About Paulina

Help